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Abstract
Background—There are no descriptions of stroke mechanisms from intracranial atherosclerotic
disease (ICAD) in native South Asian Pakistanis.
Methods—Men and women aged >/= 18 years with acute stroke presenting to four tertiary care
hospitals in Karachi, Pakistan were screened using Magnetic Resonance Angiography/
Transcranial Doppler scans. TOAST criteria were applied to identify strokes from ICAD.
Results—245 patients with acute stroke due to ICAD were studied. 230 scans were reviewed.
206 /230(89.0%) showed acute ischemia.
The most frequent presentation was with cortically based strokes in 42.2% (87/206) followed by
border zone infarcts (52/206, 25.2%).Increasing degrees of stenosis correlated with the
development of both cortical and border zone strokes (p=.002). Important associated findings were
frequent atrophy (166/230, 72.2%) silent brain infarcts (66/230, 28%) and a marked lack of severe
leukoaraiosis identified in only 68 /230 (29.6 %).
A total of 1870 arteries were studied individually. MCA was the symptomatic stroke vessel in
half, presenting with complete occlusion in 66%. Evidence of biological disease, symptomatic or
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asymptomatic was identified in 753 (40.2%) vessels of which 543 (72%) were significantly
(>50%) stenosed at presentation.
Conclusion—ICAD is a diffuse process in Pakistani South Asians, with involvement of multiple
vessels in addition to the symptomatic vessel. The MCA is the most frequent symptomatic vessel
presenting with cortical embolic infarcts. There is a relative lack of leukoaraiosis. Concomitant
atrophy, silent brain infarcts and recent ischemia in the symptomatic territory are all frequently
associated findings.
INTRODUCTION
Pakistan is the sixth most populous country in the world with a population of 170 million 1.
Over the last four decades, the incidence of stroke has increased by more than a 100% in
middle-low income countries like Pakistan 2. The estimated lifetime prevalence of
cerebrovascular disease in Pakistan has been reported to be 20% 3 which translates into 34
million individuals with either stroke or TIA. Intracranial atherosclerotic disease (ICAD)
may be the most common cause of stroke in the world especially in Pakistani South
Asians 4, 5. To inform better strategies for prevention and treatment of ICAD, a clearer
recognition of its presentation and pathophysiologic mechanisms in susceptible populations
will be helpful. In Pakistani South Asians however this has not been reported to date.
The Karachi Intracranial Stenosis Study (KISS) is a multicenter case-control study
describing the patterns and determinants of intracranial disease in an urban Pakistani
population- those most at risk for ICAD6. In this paper we describe the detailed radiologic
presentations of ICAD stroke and their mechanistic implications.
METHODS
KISS is a multicenter, hospital based, case control study of patients with intracranial
atherosclerosis and healthy stroke-free controls. Methods have been described in detail
earlier 6.
Study Site
Subjects were recruited from 4 tertiary care hospitals in Karachi, a southern metropolis of
Pakistan with a socioeconomically diverse multiethnic population. Of the contributing
hospitals, two are academic referral centers following fee-for-service models and the rest are
heavily-subsidized publicly funded hospitals. Data collection was carried out from
November 2007 to March 2010.
Sample Size
Over the study inclusion period, 1604 patients with stroke were reviewed. Of these 385
(24%) patients were found to have large artery atherosclerosis (intra or extracranial disease)
as the stroke mechanism. Within this group 314 (81.5%) were diagnosed ICAD, rest were
extracranial atherosclerosis. We further excluded 69 patients because the certainty of
diagnosis was weaker for these patients for definite ICAD as a stroke mechanism. This study
describes the radiology and stroke mechanisms of the 245 participants who had intracranial
atherosclerotic disease (ICAD), as per the modified TOAST (Trial of ORG 10172 in Acute
Stroke Treatment) criteria.7
Study Participants
All men and women aged 18 years or older presenting with stroke fulfilling WHO criteria
were recruited by trained study physicians who actively reviewed all admissions to the
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medicine or neurology wards on a daily basis. Neuro-imaging was mandatory for inclusion.
Patients receiving medical attention after 72 hours since they were last seen normal, those
diagnosed with non-vascular or iatrogenic stroke, those presenting with concomitant acute
coronary syndrome or those who refused to consent were excluded from this study.
Surrogate consent was sought if the patient was unable to consent independently.
Study procedures
Appropriate ancillary vascular and cardiac investigations to assign the patient to a diagnosis
of ICAD according to TOAST criteria were reviewed in each individual case. No patient
was assigned ‘concurrent mechanism’. If a patient had atrial fibrillation, they were classified
under cardioembolism and excluded for this review. For this analysis, those patients where
the diagnosis of ICAD was most definite were selected. All scans were reviewed by a stroke
neurologist allowing appropriate classification of each stroke patient; 10% of the scans were
read by a second neurologist to assure reliability and consistency of the angiographic data
with minimal inter-observer correlation..
A standardized Computerized Tomography (CT)/Magnetic Resonance Imaging (MRI)
reading form adapted from the work of J Wardlaw8 was used to document imaging findings.
Modifications made to the form included using angiographic data to record information on
cerebral vasculature. Every artery was examined for the number, degree and distribution of
stenosis. Biologically relevant disease ranging from atherosclerotic irregularity to
measurable stenosis was noted and measured. Another modification was made to draw out
the visualized strokes on “stroke maps”. These were derived from published papers9, 10.
This was done to better visualize stroke topography in each individual patient. The
following radiologic variables were reviewed in each patient: Stroke11, acute stroke
lesions12, silent brain infarcts13, border zone infarcts14, cortical infarctions15, lacunar
infarcts15, atrophy16, leukoaraiosis17, arterial review and assignment of symptomatic vs.
asymptomatic status9, 10.
All radiologic data was directly archived into a centralized computer using specially
designed software. The software allowed for measurements to be made for calculation of
intracranial stenosis using computerized calipers, magnify areas of interest, and quantify
stroke volumes. We used the WASID method to calculate stenosis18.
Ethical Considerations
The study protocol was approved by the relevant Ethical Review Committee. Written
informed consent and verbal assent was given by all participants or their surrogate
respondents prior to inclusion.
Statistical Analysis
All data was entered and rechecked by two different investigators. Analysis was carried out
using Statistical Package for Social Sciences (SPSS) Version 17.0 (SPSS Inc., Chicago, IL).
We calculated simple frequencies for stroke locations and subtypes, symptomatic vessels,
old vascular lesions and brain atrophy and leukoaraiosis. Means and standard deviations
were computed for percentage of stenosis in various symptomatic and asymptomatic vessels
and proportions were used for the categorical variables. Chi-square test of independence was
applied for correlations between symptomatic vessel stenosis and stroke mechanism, as well
as association of cerebral atrophy and leukoaraiosis with the number of diseased vessels.
Two sided p-value of ≤ 0.05 was taken significant.
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RESULTS
Stroke due to ICAD was the predominant mechanism of stroke due to large artery
atherosclerosis. Two hundred and forty five patients with stroke due to definite ICAD
presented to the study centers between November 2007 and March 2010. Scans (CT/MRI)
data were missing for 15 of these patients, who were, therefore, excluded. Out of the final
230 scans reviewed, a majority were judged to be of good quality (72.2%) with only 8.3%
being of poor quality. Most of the scans, 161 (70%) were MRIs with Diffusion Weighted
Imaging, 49 (21%) were non contrast CT head and 20 (9%) were plain MRIs. MR
Angiography (MRA) was available for 170 of these 230 patients.
Acute Stroke Findings
Out of the 230 scans, 24 (10.4%) had no sign of acute ischemic change at presentation. Of
these 24, 5 scans were non contrast head CT, these were not repeated. The rest (n=206,
89%) had evidence of acute ischemia with about 11 (5.4%) showing a concomitant recent
ischemic lesion. Nine of these patients had acute lesions in two territories. Only 7 (3%)
showed hemorrhagic transformation, while 56 (27.2%) had evidence of mass effect with
large infarctions. Old vascular lesions were seen in 66 of the 230 scans (28%). Most of these
were either old lacunar strokes (43.9%) or old cortical infarcts (33.3%). Only two of these
old lesions were hemorrhagic. There were no non-stroke lesions identified in the 230 scans.
Stroke Distributions and Mechanisms
(Figure 1) Of the acute strokes 151/206 (73.3%) were in the anterior circulation and the rest
(55/206, 26.7%) were in the posterior circulation. The majority were cortically based strokes
(87/206, 42.2%), followed by border-zone infarcts (52/206, 25.2%). Lacunar infarcts were
23 /206 (16%) and were the least common presentation. Cortically based strokes were more
frequent in the middle cerebral artery (MCA) territory (66/87; 75.8%). Of the borderzone
infarctions, majority were in the internal borderzone (37/52; 71.2%).
Correlation with stroke mechanism and vessel stenosis
(Figure 2) As the degree of arterial stenosis increased from <50% to complete occlusion,
there was a statistically significant increase observed in both cortical and borderzone infarcts
(p=0.002). This difference was more marked for cortically based infarctions than for
borderzone infarctions and was negligible for lacunar strokes.
Description of Angiographic findings
(Figure 3) A total of 1,870 intracranial arteries of 170 patients were studied. Of these 170
patients, 151 had acute symptomatic stroke. MCA was the symptomatic vessel in nearly half
the patients (69/151, 45.7%) with complete occlusion observed in 66% of these MCAs. ICA
and Basilar (BA) were the next common culprit vessels (25/151 each, 16.6%) (Table 1).
Evidence of biological disease (any degree of stenosis) was identified in 753 of the 1870
(40.2%) vessels studied. Significant stenosis (>50%) was found in 543 of the 753 (72%)
arteries; 433 of these 543 (79.9%) vessels with significant stenosis were asymptomatic (i.e.
not corresponding to the arterial territory of the presenting ischemic change).The greatest
number of asymptomatic significant stenosis was observed in PCAs. A mean of 4.4 vessels
were diseased per patient with the highest number of affected vessels being 10 of 11.
Associated Radiologic findings and correlations
Important associated radiologic findings were frequent atrophy 166 /230 (72.2%) and the
marked lack of leukoaraiosis identified in only 68 of the 230 patients (29.6%). There were
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no significant associations between number of diseased vessels and leukoaraiosis (p =0.55),
as well as central/ cortical atrophy (p = 0.87, 0.96 respectively).
DISCUSSION
We found that ICAD presents most frequently with cortical embolic stroke followed by
internal borderzone ischemia in Pakistani South Asians. The stroke is most often due to
advanced stenosis of the MCA, and the chances of getting a disabling cortically based stroke
correlates with advancing degrees of stenosis. ICAD interestingly, not infrequently presents
with lacunar stroke, however this presentation is not influenced by increasing stenosis in the
parent artery. Noteworthy concomitants are, associated remote silent brain infarcts, of which
one third were cortical strokes, atrophy, recent ischemia, and diffuse atherosclerosis.
Unexpectedly infrequent is diffuse white matter disease—given the distribution of risk
factors for both being similar – this observation is puzzling and unclear.
The mechanisms of stroke from ICAD in Pakistanis are heterogeneous and it is important
for the clinician to recognize these mechanisms for their potential therapeutic implications.
Studies from similar populations have shown that cortical embolic stroke in ICAD are often
accompanied by platelet microembolism measurable by doppler ultrasound19. Clinical
intervention by the use of double antiplatelet agents in this setting 20, 21 have shown both
reductions in micro-embolic signals and a reduction of recurrent stroke. Internal border-zone
stroke, the second commonest mechanism, when measured by Positron Emission
Tomography (PET) shows increased Oxygen Extraction Fraction (OEF)22 and by Single
Photon Emission CT (SPECT) shows decreased reserve on acetazolamide challenge23 and is
often also prone to progressive infarction24, 25. In actuality there are very few ICAD based
studies that tell us what intervention would be reasonable in the face of acute border-zone
ischemia. However emerging data suggests that it may not be safe to acutely reduce pressure
aggressively26 and perhaps increasing pressure may enhance flow through collaterals and
stabilize the progression.
Important also are the lacunar presentations of ICAD, these have been described in other
populations due to atheroma in the parent artery 27. Getting an expensive intracranial MRA,
when the presentation is lacunar is not intuitional for most developing country neurologists,
but recognizing this presentation for prognostic reasons is essential. ICAD carries the worst
recurrent stroke rate (15% at one year)28 amongst all ischemic stroke presentations- and at
this time evidence from Warfarin versus Aspirin in Symptomatic Intracranial Disease
(WASID) study clearly informs us that a strategy of aggressive risk factor intervention is the
only way forward 29.
Important to note is that although the chances of stroke increased with increasing degree of
stenosis, strokes of varied mechanisms were seen at all degrees of stenosis30. Autopsy
studies on fatal strokes31 and high strength magnets 32 are informing us that we need to
appreciate ICAD as a mechanism of stroke at lesser degrees of stenosis as plaque
hemorrhage and instability will ensue in both kinds of strokes regardless of the degree of
initial stenosis33. The associated “preclinical silent brain infarcts” that we report are an
additional observation supporting the emergent data on the effect of less than 50% stenosis
on brains.
Evidence of atherosclerotic disease was present in nearly half the vessels studied, with more
than 70% vessels having significant (≥ 50%) stenosis. Sixty five percent of the culprit
vessels had >70% stenosis in our study as compared to WASID which reports 40% of its
subjects having severe stenosis (>70% in single or >50% in multiple arteries) 34. A study
Khan et al. Page 5
Int J Stroke. Author manuscript; available in PMC 2014 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
from the Chinese population showed significant (≥50%) stenosis in 65% of their patients 35.
72.8% of our patients had ≥50% stenosis in their culprit vessels.
The ratio of asymptomatic stenosis was considerably high in our study (79% vs. 27% in
MRAs reviewed for WASID) 36. There are currently limited studies on asymptomatic
cerebrovascular disease. MRAs in healthy Japanese and Koreans had 3-3.5% ICAD 37, 38.
Some studies suggest that asymptomatic intracranial disease has a low risk of
recurrence 36, 39. At least in our cross sectional observation, the involvement of the middle
cerebral artery was more likely to be symptomatic and the anterior and posterior cerebral
asymptomatic, suggesting that location may determine asymptomatic status due to
collaterals 40. This hypothesis will need further testing. At the very least, if there is diffuse
involvement, intervention in high risk populations presents an opportunity to prevent
symptomatic stroke. At this stage intervention may not necessarily be technically demanding
and expensive like stents or bypass- both difficult interventions in most resource poor
countries where ICAD is common.
Leukoaraiosis was surprisingly low. As the burden of hypertension is significantly high in
our population, more was expected. In some Asian populations, significant association of
leukoaraiosis has been reported with large artery atherosclerosis 27 and with multiple
vessels 35. We are puzzled by this observation and unclear as to why there is small vessel
protection.
Lastly the cortical atrophy may be the result of chronic ischemia of multiple vessels, as in a
recent observation, revascularization reverses cortical thinning in these patients41 although
our data set failed to find a statistically significant association.
Our study is unique because the disease burden in an individual patient of ICAD has never
been quantified before in native South Asians. Our participating locations are national
referral centers for stroke, so there is broader generalizability. We followed a systemized,
centralized, standardized and supervised protocol. All our variables were predefined and
measured exactly using international guidelines. The main limitation of this study is its cross
sectional design and lack of longitudinal data. Our study population was urban and hospital
based, and our investigation uses non invasive modalities, which might lead to detection bias
of the true burden of ICAD. Also, not all scans were MRIs; CT may have missed out on
some of the asymptomatic strokes. This may have decreased the detection rate of silent
strokes –and the asymptomatic disease burden may be underreported.
Looking at the broader picture, studies aimed at alleviating stenosis in a single vessel may
be ignoring the larger problem which perhaps may respond to global interventions aimed at
halting the process of progressive pre-symptomatic ICAD42.
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Figure 1. Diffusion weighted images showing the stroke location and mechanisms in order of
frequency – most frequent to least
A. CORTICAL EMBOLIC INFARCTION a: Left anterior cerebral artery infarct; b & c:
Left middle cerebral artery infarcts; d: Bilateral cerebellar infarcts
B. BORDERZONE TERRITORIAL INFARCTIONS: e: left anterior and bilateral
posterior borderzone infarcts; f & g: Internal borderzone infarcts
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Figure 2.
Correlation of stroke mechanisms with increasing degree of atherosclerotic stenosis
(p=0.002). Advanced stenosis increases hemodynamic strokes and major cortical embolisms
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Figure 3. MRA images showing diffuse severe atherosclerotic disease in South Asian Patients
with Intracranial Atherosclerotic Disease (ICAD)
a-d: anterior circulation; frequent bilateral MCA involvement in addition to the
symptomatic vessel; e-h: posterior circulation; frequent PCA disease in addition to the
symptomatic vessel
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Table 1
Symptomatic vessel and atherosclerotic stenosis in decreasing order of frequency (n=151)
Vessel Symptomatic vessel, n (%) Mean stenosis (SD) 100% stenosis, n (%)
MCA 69 (45.7) 77.4 (36.3) 46 (66)
ICA 25 (16.6) 81.5 (27.6) 16(64)
Basilar 25 (16.6) 44.6 (45.2) 8 (32)
PCA 23 (15.2) 67.6 (39.7) 11 (47.8)
ACA 7 (4.6) 85.7 (37.7) 6 (85.7)
Vertebrals 2(1.3) 72.1 (39.3) 1 (50)
ICA= internal carotid artery; MCA= middle cerebral artery; ACA= anterior cerebral artery; PCA= posterior cerebral artery;
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